United StatesÚltimas notícias

Nurix Therapeutics (NASDAQ:NRIX), a clinical-stage biopharmaceutical company focused on small molecule therapies for cancer and immune disorders, reported its first-quarter 2026 financial results and provided a comprehensive update on its lead clinical programs on April 8, 2026.

AtaiBeckley (NASDAQ:ATAI), a clinical-stage biopharmaceutical company developing next-generation mental health treatments, reported on April 8, 2026, peer-reviewed Phase 2a results demonstrating that a single intranasal dose of BPL-003 achieved rapid and sustained clinical benefits in patients with Treatment-Resistant Depression (TRD).

Pony.ai (NASDAQ:PONY), a global leader in autonomous driving technology, reached a historic milestone on April 8, 2026, with the launch of Europe’s first commercial robotaxi service in Zagreb, Croatia.

ECARX Holdings (NASDAQ:ECX), a global leader in automotive intelligence technology, announced on April 8, 2026, that its Board of Directors has approved a preliminary plan to pursue the acquisition of a minority interest and specific intellectual property assets related to FlyMe OS.

Accenture (NYSE:ACN) has acquired Keepler Data Tech, a prominent Spanish cloud-native AI and data firm, in a strategic move to accelerate its ability to reinvent core business processes for global clients through advanced intelligence solutions.

United Microelectronics (NYSE:UMC), a leading global semiconductor foundry, reported on April 8, 2026, its unaudited net sales for March 2026, showing continued year-over-year gains in a stabilizing global chip market.

Mesoblast (NASDAQ:MESO) announced on April 7, 2026, that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to proceed directly to a registrational trial for Ryoncil® (remestemcel-L) in children with Duchenne muscular dystrophy (DMD).

Shell (NYSE:SHEL) updated its first-quarter 2026 outlook on April 8, raising its indicative refining margin to $17 per barrel while warning that the ongoing conflict in the Middle East is driving increased uncertainty across its global operations.

Hemispherian, a clinical-stage oncology company, announced on April 8, 2026, the initiation of a Phase 1/2a clinical trial for its lead candidate, GLIX1, marking a significant milestone in the development of targeted therapies for recurrent and progressive glioblastoma (GBM) and other high-grade gliomas.

CME Group (NYSE:CME) reported record international average daily volume for the first quarter of 2026, as global market participants ramped up hedging activity across interest rates and commodities amid a volatile start to the year.

PIMCO's Multi-Asset Credit Strategist Lotfi Karoui said concerns building in direct building are a little related to rapid growth. The ongoing exodus from nontraded vehicles, which make up 60% of the sector's assets, and elevated leverage in their publicly-traded counterparts are key drivers of the credit grader's revision, according to a report Tuesday. The "disruptive force" presented by artificial intelligence is expected to compound the group's worries and put it "on defense" in the coming year, Moody's analysts wrote.  An abrupt reversal in the first quarter spurred the first ever net outflow for the sector, Moody's said. Before artificial intelligence advances set off alarm bells over the durability of software securities, the vehicles had experienced robust net inflows as recently as the third quarter of 2025.

Michael Gross, Co-Founder of SLR Capital Partners said pressure on business development companies are part of private credit's "growing pains." JPMorgan Chase & Co. is restricting some lending to private credit funds after marking down the value loans in their portfolios. At the same time, BDCs which lend directly to middle-market companies are seeing elevated redemption requests amid fear of loss related to oversized exposure to software firms disrupted by AI.  Besides equity from limited partners and public investors, private credit funds rely on banks for funds. They also raise debt in the investment-grade bond market.